Parotid Neoplasms
Showing 51 - 75 of 756
Relapsed or Refractory Acute Myeloid Leukemia, Relapsed or Refractory Chronic Myelomonocytic Leukemia, Relapsed or Refractory
Recruiting
- Relapsed or Refractory Acute Myeloid Leukemia
- +2 more
-
Duarte, California
- +1 more
Mar 14, 2023
EBV-associated Lymphomas Trial ((Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell
Not yet recruiting
- EBV-associated Lymphomas
- (Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell line lysate
- (no location specified)
May 31, 2023
Coplanar Template Assistance for Head and Neck Biopsies.
Recruiting
- Head and Neck Neoplasms
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology of Peking university third hosp
May 25, 2022
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs
Not yet recruiting
- Myeloproliferative Neoplasms (MPNs)
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
- (no location specified)
Mar 24, 2023
Esophageal Tumors, Endoscopic Mucosal Resection, Hyaluronic Acid Trial in São Paulo (Submucous Endoscopic Dissection with
Recruiting
- Esophageal Neoplasms
- +2 more
- Submucous Endoscopic Dissection with hydroxyethylamide
- Submucous Endoscopic Dissection with Hyaluronic acid (TS-905 Blue Eye)
-
São Paulo, BrazilInstituto do Câncer do Estado de São Paulo
Oct 16, 2023
CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)
Not yet recruiting
- Central Nervous System Neoplasms
- +6 more
- B7-H3-CAR T cells
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 18, 2023
Hematologic Tumors Trial in Nanjing (virtual reality device)
Recruiting
- Hematologic Neoplasms
- virtual reality device
-
Nanjing, Jiangsu, Chinathe First Affiliated Hospital of Nanjing Medical University
Oct 28, 2022
Pancreatic Tumors, Periampullary Carcinoma Trial in Cleveland (other, dietary supplement, behavioral)
Enrolling by invitation
- Pancreatic Neoplasms
- Periampullary Carcinoma
- Exercise
- +3 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Center, Case Comprehensive Cance
Aug 3, 2022
Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)
Recruiting
- Myeloproliferative Neoplasm
- Fedratinib Pill
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2022
Myeloproliferative Tumors Trial in Worldwide (INCA033989, Ruxolitinib)
Recruiting
- Myeloproliferative Neoplasms
-
Herston, Queensland, Australia
- +22 more
Jun 30, 2023
Endoscopic Papillectomy in the Treatment of Ampullary Neoplasms.
Recruiting
- Ampullary Adenoma
- +3 more
- Endoscopic Papillectomy
-
Forlì, Forlì-Cesena, ItalyOspedale Morgagni-Pierantoni
Jan 20, 2023
Colorectal Tumors Trial (Fecal immunochemical test, APCS score)
Not yet recruiting
- Colorectal Neoplasms
- Fecal immunochemical test
- APCS score
- (no location specified)
Jun 29, 2022
Non-Hodgkin Lymphoma Trial in Sohag (real time pcr)
Not yet recruiting
- Non-Hodgkin Lymphoma
- real time pcr
-
Sohag, EgyptSohag University
Jun 27, 2023
Colorectal Tumors, Perforation of Rectum, Perforation Colon Trial in Belgium, France (Endoscopic submucosal dissection)
Active, not recruiting
- Colorectal Neoplasms
- +2 more
- Endoscopic submucosal dissection
-
Liège, Belgium
- +12 more
Feb 6, 2023
Colorectal Tumors Trial (Qualitative Fecal immunochemical test + APCS score, Quantitative Fecal immunochemical test)
Not yet recruiting
- Colorectal Neoplasms
- Qualitative Fecal immunochemical test + APCS score
- Quantitative Fecal immunochemical test
- (no location specified)
Jun 29, 2022
Engrailed (EN)-2 in Epithelial Ovarian Neoplasms
Completed
- Ovarian Neoplasms
- Immunohistochemical staining of normal and neoplastic ovarian tissues by anti human Engrailed-2 antibody.
-
Sohag, EgyptSohag faculty of medicine
Sep 25, 2022
EBV-associated Haematologic Tumors Trial ((Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed
Not yet recruiting
- EBV-associated Haematologic Neoplasms
- (Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell line lysate
- (no location specified)
Dec 4, 2022
T-Cell and NK-Cell Tumor Trial
Not yet recruiting
- T-Cell and NK-Cell Neoplasm
- (no location specified)
Sep 28, 2023
Epigenetic Age on Clinic-biological Presentation and Prognosis
Not yet recruiting
- Myeloproliferative Neoplasm
- Assessment of the epigenetic age
-
Bordeaux, FranceCHU de Bordeaux, service Hématologie Biologique
Aug 28, 2023
Xerostomia Following Radiotherapy Trial in Ljubljana (allogeneic mesenchymal stromal stem cells)
Not yet recruiting
- Xerostomia Following Radiotherapy
- allogeneic mesenchymal stromal stem cells
-
Ljubljana, Slovenia
- +3 more
Aug 22, 2023
Genetic Predisposition Testing Program for Pancreatic
Not yet recruiting
- Pancreatic Neuroendocrine Neoplasm
- Hereditary Cancer Panel
-
Los Angeles, California
- +2 more
Feb 17, 2023
Metastatic Tumor to the Spine, Metastatic Tumor Trial in Cleveland (Conventional external beam radiation therapy dose (EBRT),
Recruiting
- Metastatic Neoplasm to the Spine
- Metastatic Neoplasm
- Conventional external beam radiation therapy dose (EBRT)
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 24, 2023